ATE366105T1 - Stabilisierte pharmazeutische zusammensetzung enthaltend einen nsaid und einen prostaglandin - Google Patents
Stabilisierte pharmazeutische zusammensetzung enthaltend einen nsaid und einen prostaglandinInfo
- Publication number
- ATE366105T1 ATE366105T1 AT04447005T AT04447005T ATE366105T1 AT E366105 T1 ATE366105 T1 AT E366105T1 AT 04447005 T AT04447005 T AT 04447005T AT 04447005 T AT04447005 T AT 04447005T AT E366105 T1 ATE366105 T1 AT E366105T1
- Authority
- AT
- Austria
- Prior art keywords
- nsaid
- prostaglandin
- pharmaceutical composition
- composition containing
- stabilized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45182703P | 2003-03-03 | 2003-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE366105T1 true ATE366105T1 (de) | 2007-07-15 |
Family
ID=32825436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04447005T ATE366105T1 (de) | 2003-03-03 | 2004-01-09 | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nsaid und einen prostaglandin |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7303761B2 (de) |
| EP (1) | EP1462098B1 (de) |
| AT (1) | ATE366105T1 (de) |
| DE (1) | DE602004007315D1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6428809B1 (en) * | 1999-08-18 | 2002-08-06 | Microdose Technologies, Inc. | Metering and packaging of controlled release medication |
| US20070087048A1 (en) * | 2001-05-31 | 2007-04-19 | Abrams Andrew L | Oral dosage combination pharmaceutical packaging |
| CA2476101A1 (en) * | 2004-08-12 | 2006-02-12 | Bernard Charles Sherman | Extended-release capsules comprising venlafaxine hydrochloride |
| WO2006099618A1 (en) * | 2005-03-16 | 2006-09-21 | Dr. Reddy's Laboratories Ltd. | Delivery system for multiple drugs |
| ZA200801592B (en) * | 2005-07-20 | 2009-10-28 | Panacea Biotec Ltd | Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor |
| JP2009511191A (ja) * | 2005-10-14 | 2009-03-19 | マイクロドース・テクノロジーズ・インコーポレーテッド | 経口投与剤組合せ型医薬パッケージ法 |
| US7560489B2 (en) * | 2006-10-11 | 2009-07-14 | Nexmed Holdings, Inc. | Stabilized prostaglandin E composition |
| EP2142175A2 (de) * | 2007-03-30 | 2010-01-13 | Wockhardt Research Centre | Pharmazeutische zusammensetzungen aus diclofenac und misoprostol |
| US20090087483A1 (en) * | 2007-09-27 | 2009-04-02 | Sison Raymundo A | Oral dosage combination pharmaceutical packaging |
| US8439033B2 (en) | 2007-10-09 | 2013-05-14 | Microdose Therapeutx, Inc. | Inhalation device |
| WO2010071865A1 (en) | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| US20100160351A1 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| WO2011032175A1 (en) | 2009-09-14 | 2011-03-17 | Nuon Therapeutics, Inc. | Combination formulations of tranilast and allopurinol and methods related thereto |
| TWI589313B (zh) | 2010-01-05 | 2017-07-01 | 麥可朵斯斯若波特公司 | 醫藥遞送封裝及吸入器 |
| KR101378973B1 (ko) | 2012-04-13 | 2014-03-28 | 한미약품 주식회사 | 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법 |
| US20140141075A1 (en) * | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
| WO2023002338A1 (en) * | 2021-07-23 | 2023-01-26 | Avaca Pharma Private Limited | Compositions, methods of making and using same for the delivery of ulcerogenic drugs thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0527887B1 (de) * | 1990-05-03 | 1995-04-26 | G.D. Searle & Co. | Pharmazeutische zusammensetzung |
| US5213807A (en) * | 1990-05-03 | 1993-05-25 | Chemburkar Pramod B | Pharmaceutical composition containing ibuprofen and a prostaglandin |
| SE9600070D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
| IL131248A (en) * | 1997-02-19 | 2002-09-12 | Starck H C Gmbh Co Kg | Tantalum powder, process for its preparation and compressed anodes obtained from this powder |
| US6312724B1 (en) * | 1997-04-04 | 2001-11-06 | Isa Odidi | Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof |
| CA2241342C (en) | 1998-06-15 | 2000-02-08 | Bernard Charles Sherman | Pharmaceutical tablets comprising an nsaid and a prostaglandin |
| US6387410B1 (en) * | 1998-09-10 | 2002-05-14 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
| US6183779B1 (en) * | 1999-03-22 | 2001-02-06 | Pharmascience Inc. | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
| CA2277407A1 (en) * | 1999-07-14 | 2001-01-14 | Bernard Charles Sherman | Pharmaceutical tablet comprising an nsaid and misoprostol |
| US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| AU2002348105A1 (en) * | 2001-10-29 | 2003-05-12 | King Pharmaceuticals Research And Development, Inc | Oral dosage forms for improving the bioavailability of therapeutic agents |
-
2004
- 2004-01-09 AT AT04447005T patent/ATE366105T1/de not_active IP Right Cessation
- 2004-01-09 EP EP04447005A patent/EP1462098B1/de not_active Expired - Lifetime
- 2004-01-09 DE DE602004007315T patent/DE602004007315D1/de not_active Expired - Lifetime
- 2004-02-26 US US10/789,174 patent/US7303761B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004007315D1 (de) | 2007-08-16 |
| EP1462098A1 (de) | 2004-09-29 |
| EP1462098B1 (de) | 2007-07-04 |
| US20040185100A1 (en) | 2004-09-23 |
| US7303761B2 (en) | 2007-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE366105T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nsaid und einen prostaglandin | |
| AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
| DE60334773D1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
| BR0316027A (pt) | Formulações de toxina botulina para administração oral | |
| EA200401517A1 (ru) | Фармацевтический препарат для местного применения | |
| ATE303149T1 (de) | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil | |
| DE60312049D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
| CY1113128T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
| AR037248A1 (es) | Compuestos de n-benzoil-5-tiofen-2-sulfonamida y n-benzoil-2-tiazol-5-sulfonamida, formulacion farmaceutica que los comprende y su uso para fabricacion de un medicamento | |
| HN2003000272A (es) | Formulaciones que comprenden un compuesto de indolinona | |
| MXPA06011467A (es) | Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid). | |
| UY27727A1 (es) | Nueva composicion farmacéutica- | |
| ATE337016T1 (de) | Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen | |
| DK1401405T3 (da) | Orale, farmaceutiske sammensætninger med forbedret biotilgængelighed | |
| CL2004001843A1 (es) | Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax | |
| UY29561A1 (es) | Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
| ATE409040T1 (de) | Kombination enthaltend substanzen mit npy- rezeptor affinität und substanzen mit 5-ht6- rezeptor affinität | |
| EA200501565A1 (ru) | Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса | |
| IS7383A (is) | Skammtaform með stýrða lyflosun til inngjafar | |
| ATE300281T1 (de) | Entzündungshemmende arzneizubereitungen enthaltend ketoprofen | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
| ATE357220T1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
| ATE306483T1 (de) | Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung | |
| DK1109538T3 (da) | Antiinflammatoriske farmaceutiske formuleringer | |
| GT200600242A (es) | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |